BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3980806)

  • 1. Psoriasis and susceptibility to nonmelanoma skin cancer.
    Stern RS; Scotto J; Fears TR
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):67-73. PubMed ID: 3980806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA; Marcil I; Stern RS
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS; Laird N
    Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous carcinoma in psoriatic patients treated with PUVA.
    Reshad H; Challoner F; Pollock DJ; Baker H
    Br J Dermatol; 1984 Mar; 110(3):299-305. PubMed ID: 6696845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS; Bagheri S; Nichols K;
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
    Dai H; Li WQ; Qureshi AA; Han J
    J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis and the risk of cancer.
    Stern R; Zierler S; Parrish JA
    J Invest Dermatol; 1982 Feb; 78(2):147-9. PubMed ID: 7057050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study.
    Torinuki W; Tagami H
    J Am Acad Dermatol; 1988 Jun; 18(6):1278-81. PubMed ID: 3385042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Puva therapy and carcinogenesis].
    Thomas P; Pannequin C
    Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
    [No Abstract]   [Full Text] [Related]  

  • 16. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.
    Stern RS; Nichols KT
    J Pediatr; 1996 Dec; 129(6):915-7. PubMed ID: 8969737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
    Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB
    N Engl J Med; 1979 Apr; 300(15):809-13. PubMed ID: 423919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE; Stern RS
    J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.